Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Granzotto M"'
Autor:
Claudio Tripodo, Marilena Granzotto, Sara Capolla, Gabriele Pozzato, Ruben Spretz, Michele Dal Bo, Luis Nunez, Sonia Zorzet, Paolo Macor, Gustavo Larsen, Sandra Noriega, Nelly Mezzaroba, Eduardo Mansilla, Francesca Vita, Ramiro Mendoza-Maldonado, Valter Gattei
Publikováno v:
Nano Research. 9:537-548
Current approaches for the treatment of chronic lymphocytic leukemia (CLL) have greatly improved the prognosis for survival, but some patients remain refractive to these therapeutic regimens. Hence, in addition to reducing the long-term sideeffects o
Autor:
Alessandro Ventura, Sara Dal Bo, Elisa Piscianz, Tarcisio Not, Stefano Martelossi, Erica Valencic, Marilena Granzotto, Fortunato Ferrara, S Quaglia, Alberto Tommasini
Celiac disease (CD) is characterized by intolerance to gluten and high risk of developing autoimmune phenomena. Possible defects in immune tolerance could have a role in the pathogenesis of the disease. As regulatory T-cells (Tregs) are the main popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e66d9b677d869c006e44d9ceb19045
https://hdl.handle.net/11368/1854338
https://hdl.handle.net/11368/1854338
Autor:
M. Granzotto, Beatrice Perissutti, Karin Woelkart, Dario Voinovich, P. Guiotto, Rudolf Bauer, Sergio Invernizzi, Iztok Grabnar
The relative bioavailability of the major alkamides, dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides, from Echinacea purpurea phytotherapeutic lozenges at three different dose levels (0.07, 0.21 and 0.9 mg) was evaluated in a pharmacokinetic stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e0e65f6361b8caa0767e7d62255f25
http://hdl.handle.net/11368/1849081
http://hdl.handle.net/11368/1849081
Autor:
Andrea D'Osualdo, Alessandro Ventura, Sergio Crovella, Hans R. Waterham, Lorenzo Calligaris, Marco Nevyjel, Alessandra Pontillo, Alberto Tommasini, Egidio Barbi, Marilena Granzotto
Publikováno v:
Pediatrics, 119(2), e523-e527. American Academy of Pediatrics
Mevalonate kinase deficiency is a rare inborn disorder of isoprenoid and sterol biosynthesis characterized by a recurrent autoinflammatory syndrome and, in most severe cases, psychomotor delay. Clinical manifestations can be very complex and, in some
Autor:
Egidio Barbi, Alberto Tommasini, Andrea Taddio, Erica Valencic, Alessandro Ventura, M. Andolina, Marilena Granzotto, Elena Faleschini, Loredana Lepore
This work studies IPEX (Immunodysregulation with Polyendocrinopathy and Enteropathy X-linked), a severe disorder of course in early childhood due to mutations in the FOXP3 gene (locus Xp11.23-q13.3) leading to failure in immune tolerance and his ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf93436405d1828099141427433efd6
https://hdl.handle.net/11368/1702669
https://hdl.handle.net/11368/1702669
Autor:
Francesca Gombac, Marlenka Zerial, Valentina Leone, Alberto Tommasini, Loredana Lepore, Alessandro Ventura, Roberta Ciambra, Marilena Granzotto
Publikováno v:
Pediatric hematology and oncology. 22(2)
Chronic granulomatous disease (CGD) is a rare genetically determined immunodeficiency. Neutrophils from CGD patients show a defective killing of phagocytosed fungi and bacteria, due not only to an impairment in oxidative burst, but also to absence of
Autor:
Fiora Bartoli, Tullio Giraldi, Giuliana Decorti, Marilena Granzotto, Luigi Candussio, Enrico Crivellato, A.M. Rosati
The effect of a chronic treatment with low oral doses of verapamil, a calcium channel blocker commonly employed in cardiovascular therapy, on doxorubicin toxicity, was evaluated in CD1 mice. Verapamil, administered at a dosage corresponding to a typi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0624a9185046f3ad372abd7d02b25818
https://hdl.handle.net/11368/1691861
https://hdl.handle.net/11368/1691861
Autor:
Chiara Garrovo, Gustavo Horacio Marín, Marilena Granzotto, Gabriele Baj, Sonia Zorzet, Luis Nunez, Stefania Biffi, Nelly Mezzaroba, Ruben Spretz, Sandra Noriega, Marianna Lucafò, Eduardo Mansilla, Erika Secco, Gustavo Larsen, Valter Gattei, Marco Calvaruso, Ramiro Mendoza-Maldonado, Sara Capolla, Gabriele Pozzato, Claudio Tripodo, Paolo Macor
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74216 (2013)
PLoS ONE
PLoS ONE
Current B-cell disorder treatments take advantage of dose-intensive chemotherapy regimens and immunotherapy via use of monoclonal antibodies. Unfortunately, they may lead to insufficient tumor distribution of therapeutic agents, and often cause adver